While U.S. legacy outlets recycle moral panic, South America’s business establishment is already treating cannabis like a real market, and demanding rules that actually work.
In the United States, cannabis is stuck in a weird loop.
No real federal program that matches reality. Fifty different rulebooks pretending they’re a country. A hemp market that keeps getting yanked around like a political chew toy. And in the middle of it, the loudest mainstream megaphones (New York Times, Wall Street Journal, New York Post) keep circling the same tired story: fear, vibes, moral panic, “think of the children,” and a stubborn refusal to look straight at the evidence, the economics, and the fact that this is already a regulated industry employing hundreds of thousands of people.
You can feel it in the headlines and the framing. When America’s legacy press talks about weed, it often reads like a scare package searching for a crisis.
Now jump south.
Argentina, a country outsiders still stereotype as “more conservative,” “more bureaucratic,” “less flexible,” just hosted a cannabis business event that landed in a place you would not expect if your mental map is stuck in 2010.
Ámbito, Argentina’s business-and-markets establishment publication (a WSJ-style outlet, but in Spanish), hosted CannaB2B through its Ámbito Debate platform, together with El Planteo, a cannabis outlet that has become a reference point across Spanish-speaking markets. And the vibe was the opposite of American fearmongering.
Not “weed is melting brains.”
More like: Ok, this economy exists. It’s hiring people. It’s moving money. It’s building supply chains. The only question is whether the state is going to stop tripping over itself long enough for the sector to scale.
That contrast is the story.
Because Ámbito isn’t a stoner zine discovering the plant for the first time. It’s a finance-first outlet that has historically positioned itself as a voice for the country’s financial establishment and stock market readership. And Ámbito Debate is where it convenes “real economy” conversations: mining, energy, tourism, technology, the stuff a country argues about when it’s trying to stay competitive and attract capital.
So when that ecosystem decides cannabis belongs in the room, that’s not a lifestyle trend.
That’s a signal.
A market that exists in real life, and barely exists on paper
The most honest line of the day came from Luis Osler, president of CAINCCA, who basically described Argentina’s cannabis sector as a functioning machine that the state refuses to admit is turned on:
“We got used to using terms that aren’t real. The cannabis industry exists in practice, with entrepreneurs, SMEs, and people who grind every day, but formally it doesn’t exist.”
That is Argentina’s central contradiction in one punch.
There are laws. There’s demand. There are operators. There are associations. There’s capital sniffing around. There’s a professional class built around compliance, genetics, cultivation systems, logistics, and medical access.
But the licensing bottlenecks and the stop-start regulatory posture keep the whole thing hovering in limbo, like the country is allergic to admitting what’s already true.
Ivana Sol Vigilante, founder of Welegal, put the blame where business audiences rarely hear it said out loud, on the execution layer:
“The laws are in place. What’s missing is for the Executive Branch to respect them so the industry can take off.”
That framing matters. It flips cannabis from “controversy” to “governance.” Not a moral argument. A state capacity problem.
“If there are no clear rules, where does investment go?”
Martín Rodolfo Galván from Delta 9 Consultora hit the nerve that business rooms care about first: predictability.
“There’s a lot of investment in the middle. If there are no clear rules, where is it going to go?”
He also stressed something the U.S. conversation loves to blur: “medical” and “industrial” are not the same game. They have different requirements, different gatekeepers, different risk profiles. If you want to cultivate, export, scale, or build services around the plant, good intentions don’t matter. Process does.
The chain is the industry, not the flower
One of the cleanest takeaways from CannaB2B was how little time serious operators spend romanticizing the plant.
Manuel Regidor García from Mountain Seeds put it plainly:
“We strongly believe the value of cannabis isn’t in a single product, it’s in the chain.”
That sentence is the antidote to America’s mainstream media problem.
Because panic framing is built to ignore the reality that cannabis, like any regulated sector, is mostly boring systems: supply chains, quality standards, insurance, financing, traceability, compliance, recordkeeping, logistics.
Noemí “Mimi” Pérez of CannaID and GreenBook Academy, who works across multiple markets, pushed the same idea from a different angle, the one that kills the “weed culture” cliché on contact:
“This is an industry like any other. It needs the people who produce the raw material and all the supporting businesses around it.”
Then she hit the simplest truth that fear-based coverage keeps dodging:
“The engine of the industry is the patient or the customer. If it starts moving, everything else follows.”
In other words: stop treating cannabis like a cultural ghost story. Treat it like demand, infrastructure, and rules.
Export is the play, but it’s a long game
Argentina’s business press understands export logic instinctively because the country lives and dies by it.
Santiago Augusto from Cannafis gave the kind of quote that should be stapled to every pitch deck in every emerging market:
“Cannabis is a long road. Anyone who tells you it’s short is lying.”
And he went straight to the core:
“The process of certifications and traceability, which is the most important thing in a regulated market, takes time. It can take five years.”
No hype. No fantasies. No overnight boom. Just the truth about what it takes to sell into serious markets: documentation, audit trails, standards, patience.
Demand is real. The legal shapes are still awkward.
If the first half of the story is “business press treats cannabis like a sector,” the second half is “the sector is still forced into weird legal shapes.”
That’s where clubs and associations come in, and where you can see the pressure building under the surface: staff, compliance, cultivation schedules, patient expectations, and a regulatory posture that still treats much of it like an exception instead of a system.
Mau La Monica of Flowers and Terps didn’t need to talk about big numbers to make the point. He talked about friction, ceilings, and the sheer mismatch between demand and the forms available to meet it:
“We’ve opened registration twice in two years and got more than 4,000 requests. The limitation is the number and the way the system works.”
Jimena Oviedo of Babilon High went even more blunt, describing what happens when you force an economic reality into a nonprofit costume that was never designed for scale:
“The model of civil associations fell short for the economic scale of many projects.”
That’s microeconomics. And it’s a governance question. When activity grows faster than the legal categories, the market doesn’t stop. It just contorts.
Mariana Radisic Koliren of El Joint Club added another layer that sounds obvious the second you hear it, and insane that it still isn’t solved: medical cannabis tourism is already here, but the paperwork can’t keep up.
“There’s a massive economic opportunity with tourists who arrive with medical authorizations from another country.”
That’s Argentina in a nutshell right now. Real-world behavior is ahead of the forms. Demand is transnational. The market is already operating. The state still acts surprised it exists.
“We need private capital because the demand is there.”
And then there’s the “grown-up economy” angle: scale, investment cycles, and what happens when public and private models collide.
Ignacio Bruera, president of state-backed Cannava SE in Jujuy, framed it like a company briefing, not a cultural debate:
“We’re opening up to private capital to scale and grow, because the demand is there.”
That’s not a stoner soundbite. That’s an establishment-sector sentence. The kind of line you hear in energy, mining, logistics, agribusiness. The kind of line that tells you cannabis is not asking for permission in Argentina. It’s asking for a functioning framework.
Why this matters more than the event itself
CannaB2B wasn’t important because it was a conference.
It mattered because of who decided cannabis belonged in the conversation, and how they framed it.
In the U.S., cannabis is still too often treated as a cultural threat by mainstream editorial instinct, even while the legal market becomes more entrenched and the evidence base gets stronger.
In Argentina, the signal was: the business establishment press is willing to host the conversation, put credible operators and lawyers onstage, and treat cannabis as what it is, a complex economic sector that needs rules that function.
Ámbito’s participation is the proxy.
It’s the “wait, this room is talking about weed?” moment.
And it hints at what the next phase looks like in emerging markets: not counterculture pleading to be tolerated, but industry demanding regulatory clarity so it can scale, export, insure, finance, hire, and build.
That’s not naïve optimism. It’s just a more adult conversation.
And right now, “adult conversation” is exactly what America’s mainstream cannabis coverage keeps refusing to have.
